vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1149Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWРОЛЬ ОКСИДА АЗОТА В РАЗВИТИИ ЗАБОЛЕВАНИЙ КОЖИTHE ROLE OF NITRIC OXIDE IN DEVELOPMENT OF SKIN DISEASESСмирноваИ.Ю.SmirnovaI.Yu.ОгородоваЛ.М.OgorodovaL.M.ДеевИ.А.DeevI.A.Сибирский государственный медицинский университет, ТомскРоссияSiberian State Medical University, TomskRussian Federation20092309201584Вопросы современной педиатрии9094Copyright © Смирнова И., Огородова Л., Деев И., 20092009Смирнова И., Огородова Л., Деев И.Smirnova I., Ogorodova L., Deev I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1149ReferencesМетельская В. А., Гуманова Н. Г. Скрининг-метод определения уровня метаболитов оксида азота в сыворотке крови. Клиническая лабораторная диагностика. 2005; 6: 15 –18.Метельская В. А., Гуманова Н. Г. Скрининг-метод определения уровня метаболитов оксида азота в сыворотке крови. Клиническая лабораторная диагностика. 2005; 6: 15 –18.Bruch–Gerharz D., Kolb–Bachofen V., Ruzicka T. Nitric oxide and its implications in skin homeostasis and disease. Arch. Dermatol. Res. 1998; 2: 643–651.Bruch–Gerharz D., Kolb–Bachofen V., Ruzicka T. Nitric oxide and its implications in skin homeostasis and disease. Arch. Dermatol. Res. 1998; 2: 643–651.Michel Th., Feron O. Nitric Oxide Synthases: which, where, how, and why? J. Clin. Invest. 1997; 100: 2146–2152.Michel Th., Feron O. Nitric Oxide Synthases: which, where, how, and why? J. Clin. Invest. 1997; 100: 2146–2152.Cals–Grierson M.M., Ormerod A.D. Nitric oxide function in the skin. Nitric oxide. 2004; 10: 179–193.Cals–Grierson M.M., Ormerod A.D. Nitric oxide function in the skin. Nitric oxide. 2004; 10: 179–193.Ricciardolo F. L., Sterk P. J., Gaston B. et al. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 2004; 84: 731–765.Ricciardolo F. L., Sterk P. J., Gaston B. et al. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 2004; 84: 731–765.Nguen T., Branson D., Crespi C. L. et al. DNA damage and mutation in humane cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA. 1992; 89: 3030–3034.Nguen T., Branson D., Crespi C. L. et al. DNA damage and mutation in humane cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA. 1992; 89: 3030–3034.Bruch-Gerharz D., Ruzicka T., Ruzicka T. et al. Nitric oxide in human skin: current status and future prospects. J. Invest. Dermatol. 1998; 110 (1): 80–89.Bruch-Gerharz D., Ruzicka T., Ruzicka T. et al. Nitric oxide in human skin: current status and future prospects. J. Invest. Dermatol. 1998; 110 (1): 80–89.Hamalainen M., Korhonen R. Moilanen E. Calcineurin inhibitors down-regulate iNOS expression by destabilising mRNA. Int. Immunopharmacol. 2008; 8: 61–66.Hamalainen M., Korhonen R. Moilanen E. Calcineurin inhibitors down-regulate iNOS expression by destabilising mRNA. Int. Immunopharmacol. 2008; 8: 61–66.Frank S., Kampfer H., Wetzler C. et al. Nitric oxide drives skin repair: Novel functions of an established mediator. Kidney International. 2002; 61: 882–888.Frank S., Kampfer H., Wetzler C. et al. Nitric oxide drives skin repair: Novel functions of an established mediator. Kidney International. 2002; 61: 882–888.Yamasaki K., Edington H. D., McClosky C. et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Invest. 1998; 101: 967–971.Yamasaki K., Edington H. D., McClosky C. et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Invest. 1998; 101: 967–971.Luo J. D., Chen A. F. Nitric oxide: a newly discovered function on wound healing. Act. Pharmacol. Sin. 2005; 26 (3): 59–64.Luo J. D., Chen A. F. Nitric oxide: a newly discovered function on wound healing. Act. Pharmacol. Sin. 2005; 26 (3): 59–64.Schaffer M. R., Efron P. A., Thornton F. J. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J. Immunol. 1997; 158: 2375–2381.Schaffer M. R., Efron P. A., Thornton F. J. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J. Immunol. 1997; 158: 2375–2381.Wang R., Ghahary A., Shen Y. J. Nitric oxide synthase expression and nitric oxide production are reduced in hypertrophic scar tissue and fibroblasts. J. Invest. Dermatol. 1997; 108: 438–444.Wang R., Ghahary A., Shen Y. J. Nitric oxide synthase expression and nitric oxide production are reduced in hypertrophic scar tissue and fibroblasts. J. Invest. Dermatol. 1997; 108: 438–444.Sirsjo A., Karlsson M., Gidlof A. et al. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokinestimulated cultured keratinocytes. J. Dermatol. 1996; 134: 643–648.Sirsjo A., Karlsson M., Gidlof A. et al. Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokinestimulated cultured keratinocytes. J. Dermatol. 1996; 134: 643–648.Neeta G., Vasudha B., Dakshayani P. et al. A study of serum nitric oxide levels in psoriasis. Indian J. Dermatol Venerol. Leprol. 2005; 71 (3): 198–203.Neeta G., Vasudha B., Dakshayani P. et al. A study of serum nitric oxide levels in psoriasis. Indian J. Dermatol Venerol. Leprol. 2005; 71 (3): 198–203.Krischel V., Bruch–Gerharz D., Suschek C. et al. Biphasic effect of exogenous nitric oxide (NO) on proliferation and differentiation in skin-derived keratinocytes but not fibroblasts. J. Invest. Dermatol. 1998; 111: 286–291.Krischel V., Bruch–Gerharz D., Suschek C. et al. Biphasic effect of exogenous nitric oxide (NO) on proliferation and differentiation in skin-derived keratinocytes but not fibroblasts. J. Invest. Dermatol. 1998; 111: 286–291.Bruch-Gerharz D., Schnorr O., Suschek C. et al. Arginase 1 overexpression in psoriasis. Limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyteBruch-Gerharz D., Schnorr O., Suschek C. et al. Arginase 1 overexpression in psoriasis. Limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyteHyperproliferation. Amerian J. Pathol. 2001; 173: 2375–2381.Hyperproliferation. Amerian J. Pathol. 2001; 173: 2375–2381.Xei K., Dong Z., Filder I. J. Activation of nitric oxide synthase genefor ingibition cancer metastasis. J. Leukoc. Biol. 1996; 59 (5): 797–803.Xei K., Dong Z., Filder I. J. Activation of nitric oxide synthase genefor ingibition cancer metastasis. J. Leukoc. Biol. 1996; 59 (5): 797–803.Wink D. A., Vodovotz Y., Laval J. et al. The multifaceted roles of nitric oxide. Carcinagenes. 1998; 19 (5): 711–721.Wink D. A., Vodovotz Y., Laval J. et al. The multifaceted roles of nitric oxide. Carcinagenes. 1998; 19 (5): 711–721.Wu N. Z., Klitzmen B., Dodge R. et al. Diminished leukocyteendothelium interaction in tumor microvessels. Cancer Res. 1992; 52: 4265–4268.Wu N. Z., Klitzmen B., Dodge R. et al. Diminished leukocyteendothelium interaction in tumor microvessels. Cancer Res. 1992; 52: 4265–4268.Fecker L. F., Eberle J., Orfanos C. E. et al. Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-ᾳ, interferon-γ, and lipopolysaccharide. J. Invest. Dermat. 2002; 118: 1019–1025.Fecker L. F., Eberle J., Orfanos C. E. et al. Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-ᾳ, interferon-γ, and lipopolysaccharide. J. Invest. Dermat. 2002; 118: 1019–1025.Becherel P.A., Chosidow O., Goff L.L. et al. Inducible nitric oxide sinthase and proinflammatory cytokine expression by human keratinicytes during acute urticarial. Molecular Medicine. 1997; 3 (10): 686–694.Becherel P.A., Chosidow O., Goff L.L. et al. Inducible nitric oxide sinthase and proinflammatory cytokine expression by human keratinicytes during acute urticarial. Molecular Medicine. 1997; 3 (10): 686–694.Xie Q. W., Nathan C. The high-output nitric oxide pathway: role and regulation. J. Leukoc. Biol. 1996; 56: 576–582.Xie Q. W., Nathan C. The high-output nitric oxide pathway: role and regulation. J. Leukoc. Biol. 1996; 56: 576–582.Rowe A., Farrell A. M., Bunker C. B. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br. J. Dermatol. 1997; 136 (1): 18–23.Rowe A., Farrell A. M., Bunker C. B. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br. J. Dermatol. 1997; 136 (1): 18–23.Taniuchi S., Kojima T., Hara M. et al. Increased serum nitrate levels in infants with atopic dermatitis. Allergy. 2001; 56 (7): 693–695.Taniuchi S., Kojima T., Hara M. et al. Increased serum nitrate levels in infants with atopic dermatitis. Allergy. 2001; 56 (7): 693–695.Guzik T. J., Adamek–Guzik T., Ccerniawska–Mysik G. et al. Nitric oxide metabolite levels in children and adult patients with atopic eczema/dermatitis syndrome. Allergy. 2002; 57: 856–857.Guzik T. J., Adamek–Guzik T., Ccerniawska–Mysik G. et al. Nitric oxide metabolite levels in children and adult patients with atopic eczema/dermatitis syndrome. Allergy. 2002; 57: 856–857.Mocellin S., Provenzano M., Rossi C. R. et al. Induction of endothelial nitric oxide synthase expression by melanoma sensitizes endothelial cells to tumor necrosis factor driven cytotoxicity. Clin. Cancer Res. 2004; 10 (10): 6879–6886.Mocellin S., Provenzano M., Rossi C. R. et al. Induction of endothelial nitric oxide synthase expression by melanoma sensitizes endothelial cells to tumor necrosis factor driven cytotoxicity. Clin. Cancer Res. 2004; 10 (10): 6879–6886.Chaudhuri C., Paul A. K., Acharia A. et al. Treatment of chronic anal fissure with topical gliceril trinitrate: a double blind, placebo controlled trial Indian. J. Gastroenterol. 2001; 20: 101–102.Chaudhuri C., Paul A. K., Acharia A. et al. Treatment of chronic anal fissure with topical gliceril trinitrate: a double blind, placebo controlled trial Indian. J. Gastroenterol. 2001; 20: 101–102.Trikha P., Sharma N., Athar M. Nitroglycerin: a NO donor ingibits TPA mediated tumor promotion in murine skin. Carcinogenes. 2001; 22: 1207–1211.Trikha P., Sharma N., Athar M. Nitroglycerin: a NO donor ingibits TPA mediated tumor promotion in murine skin. Carcinogenes. 2001; 22: 1207–1211.
The authors declare that there are no conflicts of interest present.